Jorge J Castillo1, Randall R Ingham2, John L Reagan2, Michael Furman3, Samir Dalia4, Joanna Mitri5. 1. Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA. Electronic address: jorgej_castillo@dfci.harvard.edu. 2. Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI. 3. Department of Medicine, Rhode Island Hospital, Providence, RI. 4. Division of Hematology and Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL. 5. Service of Endocrinology, Prima CARE, Fall River, MA.
Abstract
BACKGROUND: The relation between body mass index (BMI) and incidence of diffuse large B-cell lymphoma (DLBCL) has been suggested, but no systematic review has been undertaken. MATERIAL AND METHODS: We performed a literature search through December 2012. Meta-analyses were performed to quantify the relative risk (RR) of DLBCL incidence in overweight and obese persons compared with normal weight individuals using the random-effects model. Subset analyses were performed according to study design, sex, and geographic region. Overweight was defined as a BMI 25 to 29.9 kg/m(2), and obesity was defined as a BMI of 30 kg/m(2). Meta-regression, using an unrestricted maximum likelihood model, was performed to evaluate the linear association between BMI and odds of DLBCL. RESULTS: Our study included 6 case-control and 10 cohort studies. The RR of DLBCL in overweight individuals was 1.14 (95% confidence interval [CI], 1.04-1.24; P = .004), and in obese individuals, RR was 1.29 (95% CI, 1.16-1.43; P < .001). The RR of DLBCL in overweight men and women was 1.22 and 1.27, respectively. In overweight individuals, both prospective and case-control studies showed an RR of 1.13. The RR of DLBCL in obese men and women was 1.40 and 1.34, respectively. In obese individuals, the RR in prospective studies was 1.25 and in case-control studies it was 1.33. Meta-regression analysis showed a 14% increase in DLBCL incidence for each 10 kg/m(2) increase in BMI. CONCLUSION: An increased BMI is associated with higher RR of DLBCL regardless of sex. Also, there seems to be a linear association between BMI and DLBCL incidence.
BACKGROUND: The relation between body mass index (BMI) and incidence of diffuse large B-cell lymphoma (DLBCL) has been suggested, but no systematic review has been undertaken. MATERIAL AND METHODS: We performed a literature search through December 2012. Meta-analyses were performed to quantify the relative risk (RR) of DLBCL incidence in overweight and obesepersons compared with normal weight individuals using the random-effects model. Subset analyses were performed according to study design, sex, and geographic region. Overweight was defined as a BMI 25 to 29.9 kg/m(2), and obesity was defined as a BMI of 30 kg/m(2). Meta-regression, using an unrestricted maximum likelihood model, was performed to evaluate the linear association between BMI and odds of DLBCL. RESULTS: Our study included 6 case-control and 10 cohort studies. The RR of DLBCL in overweight individuals was 1.14 (95% confidence interval [CI], 1.04-1.24; P = .004), and in obese individuals, RR was 1.29 (95% CI, 1.16-1.43; P < .001). The RR of DLBCL in overweight men and women was 1.22 and 1.27, respectively. In overweight individuals, both prospective and case-control studies showed an RR of 1.13. The RR of DLBCL in obesemen and women was 1.40 and 1.34, respectively. In obese individuals, the RR in prospective studies was 1.25 and in case-control studies it was 1.33. Meta-regression analysis showed a 14% increase in DLBCL incidence for each 10 kg/m(2) increase in BMI. CONCLUSION: An increased BMI is associated with higher RR of DLBCL regardless of sex. Also, there seems to be a linear association between BMI and DLBCL incidence.
Authors: Eleanor Kane; Christine F Skibola; Paige M Bracci; James R Cerhan; Laura Costas; Karin Ekström Smedby; Elizabeth A Holly; Marc Maynadié; Anne J Novak; Tracy J Lightfoot; Stephen M Ansell; Alex G Smith; Mark Liebow; Mads Melbye; Lindsay Morton; Silvia de Sanjosé; Susan L Slager; Sophia S Wang; Yawei Zhang; Tongzhang Zheng; Eve Roman Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-11 Impact factor: 4.254
Authors: Siwen Wang; Yi-Xin Wang; Helena Sandoval-Insausti; Leslie V Farland; Jan L Shifren; Dan Zhang; JoAnn E Manson; Brenda M Birmann; Walter C Willett; Edward L Giovannucci; Stacey A Missmer; Jorge E Chavarro Journal: Hum Reprod Date: 2022-01-28 Impact factor: 6.918
Authors: Inna Y Gong; Matthew C Cheung; Stephanie Read; Yingbo Na; Iliana C Lega; Lorraine L Lipscombe Journal: Diabetologia Date: 2021-01-06 Impact factor: 10.122
Authors: Maria Kyrgiou; Ilkka Kalliala; Georgios Markozannes; Marc J Gunter; Evangelos Paraskevaidis; Hani Gabra; Pierre Martin-Hirsch; Konstantinos K Tsilidis Journal: BMJ Date: 2017-02-28
Authors: Jianqing Zhang; Daniel Medina-Cleghorn; Leon Bernal-Mizrachi; Paige M Bracci; Alan Hubbard; Lucia Conde; Jacques Riby; Daniel K Nomura; Christine F Skibola Journal: Oncoscience Date: 2016-01-30